Merck (BSP:MRCK34) E10: R$2.69 (As of Mar. 2026)


BSP:MRCK34 Merck & Co Inc BSP:MRCK34
77 GF Score
Price R$83.04
GF Value R$75.97
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck E10?

Merck BSP:MRCK34 +0.61% 77 E10 is R$2.69 as of Mar. 2026. GuruFocus rates BSP:MRCK34 with a GF Score™ of 77/100 and a GF Value™ of R$75.97 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Merck's adjusted earnings per share data for the three months ended in Mar. 2026 was R$-1.124. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$2.69 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Merck's average E10 Growth Rate was 6.80% per year. During the past 3 years, the average E10 Growth Rate was 7.10% per year. During the past 5 years, the average E10 Growth Rate was 9.60% per year. During the past 10 years, the average E10 Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Merck was 15.80% per year. The lowest was -6.40% per year. And the median was 2.60% per year.

As of today (2026-06-29), Merck's current stock price is R$83.04. Merck's E10 for the quarter that ended in Mar. 2026 was R$2.69. Merck's Shiller PE Ratio of today is 30.87.

During the past 13 years, the highest Shiller PE Ratio of Merck was 39.37. The lowest was 19.66. And the median was 28.52.


Merck  (BSP:MRCK34) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Merck's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=83.04/2.69
=30.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Merck was 39.37. The lowest was 19.66. And the median was 28.52.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Merck E10 Related Terms


Merck E10 Historical Data

* Premium members only.

The historical data trend for Merck's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck E10 Chart

Merck Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.06 2.24 2.03 2.75 2.92

Merck Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.72 2.69 2.75 2.92 2.69

BSP:MRCK34 vs AMGN, ABBV, GILD: E10 Comparison

For the Drug Manufacturers - General subindustry, Merck's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Shiller PE Ratio falls into.


BSP:MRCK34
77GF Score
Merck & Co Inc BSP:MRCK34
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merck E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.124/330.2130*330.2130
=-1.124

Current CPI (Mar. 2026) = 330.2130.

Merck Quarterly Data

per share eps CPI Adj_EPS
201606 0.184 241.018 0.252
201609 0.317 241.428 0.434
201612 0.176 241.432 0.241
201703 0.219 243.801 0.297
201706 0.292 244.955 0.394
201709 -0.008 246.819 -0.011
201712 -0.133 246.524 -0.178
201803 0.111 249.554 0.147
201806 0.297 251.989 0.389
201809 0.375 252.439 0.491
201812 0.335 251.233 0.440
201903 0.538 254.202 0.699
201906 0.496 256.143 0.639
201909 0.381 256.759 0.490
201912 0.472 256.974 0.607
202003 0.770 258.115 0.985
202006 0.765 257.797 0.980
202009 0.783 260.280 0.993
202012 -0.534 260.474 -0.677
202103 0.880 264.877 1.097
202106 0.383 271.696 0.465
202109 1.188 274.310 1.430
202112 1.046 278.802 1.239
202203 1.057 287.504 1.214
202206 0.978 296.311 1.090
202209 0.839 296.808 0.933
202212 0.774 296.797 0.861
202303 0.723 301.836 0.791
202306 -1.426 305.109 -1.543
202309 1.148 307.789 1.232
202312 -0.294 306.746 -0.316
202403 1.164 312.332 1.231
202406 1.441 314.175 1.515
202409 0.858 315.301 0.899
202412 1.129 315.605 1.181
202503 1.447 319.799 1.494
202506 1.220 322.561 1.249
202509 1.555 324.800 1.581
202512 0.812 324.054 0.827
202603 -1.124 330.213 -1.124

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of R$2.69 mean?
Merck (BSP:MRCK34) has a E10 of R$2.69 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Merck and its competitors.
Is Merck's E10 too high?
Merck's current E10 is R$2.69. Overall, Merck has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Merck's E10 compare to AMGN and ABBV?
Merck's E10 of R$2.69 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Merck and its competitors. Merck's current E10 is R$2.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck stock overvalued right now?
Based on GuruFocus' analysis, Merck (BSP:MRCK34) is currently considered Fairly Valued. The stock's GF Value™ is R$75.97, compared to a current price of R$83.04 — trading 9.3% above its estimated fair value. The current E10 is R$2.69. Merck's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Merck (BSP:MRCK34), the current E10 is R$2.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck (BSP:MRCK34) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of R$83.04 is trading 9.3% above its estimated GF Value™ of R$75.97. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for BSP:MRCK34:

  • E10: R$2.69
  • GF Value™: R$75.97 vs. price of R$83.04 (9.3% above fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the BSP:MRCK34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
77GF Score

Get the complete analysis for BSP:MRCK34

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$83.04
Price
R$75.97
GF Value